Aug 12 (Reuters) - The U.S. Food and Drug Administration
has approved Insmed's ( INSM ) oral drug for a type of lung
disease, the company said on Tuesday, making it the first
treatment for the chronic condition.
(Reporting by Christy Santhosh and Unnamalai L in Bengaluru;
Editing by Sriraj Kalluvila)